Bioregenx (BRGX) Beginning Cash Balance (2022 - 2023)
Bioregenx (BRGX) recorded quarterly Beginning Cash Balance of $190891.0 in Q4 2023, up 210.41% quarter-over-quarter from -$172890.0 in Q2 2023, and up 27170.14% on a YoY basis from N/an in Q4 2022.
Bioregenx (BRGX) Beginning Cash Balance (2022 - 2023) Analysis & Trends
Bioregenx's Beginning Cash Balance history runs 2 years deep, the most recent figure standing at $190891.0 for Q4 2023.
- In Q4 2023, Beginning Cash Balance rose 27170.14% year-over-year to $190891.0; the TTM figure through Mar 2024 stood at $18001.0 (down 37.86% YoY), while the FY2023 annual figure was $191001.0, up 27185.86% from the prior year.
- Beginning Cash Balance was $190891.0 for Q4 2023 at Bioregenx, up from -$172890.0 in the prior quarter.
- In the past five years, Beginning Cash Balance ranged from a high of $190891.0 in Q4 2023 to a low of -$172890.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn |
| 10 | Bioregenx | - | - | 348,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 190,891.00 |
| Dec 31, 2023 | 190,891.00 |
| Jun 30, 2023 | -172,890.00 |
| Jun 30, 2023 | -172,890.00 |
| Mar 31, 2023 | 28,270.00 |
| Mar 31, 2023 | 28,270.00 |
| Dec 31, 2022 | 700.00 |
| Dec 31, 2022 | 700.00 |